Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Talis Biomedical Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TLIS
Nasdaq
8731
https://talisbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Talis Biomedical Corp
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
- Nov 14th, 2023 1:00 pm
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
- Aug 10th, 2023 8:05 pm
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
- Aug 3rd, 2023 12:00 pm
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
- Aug 2nd, 2023 12:00 pm
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
- Jul 27th, 2023 12:00 pm
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Jul 24th, 2023 12:00 pm
Talis Biomedical Announces 1-for-15 Reverse Stock Split
- Jul 5th, 2023 12:00 pm
Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director
- May 23rd, 2023 12:00 pm
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
- May 11th, 2023 8:05 pm
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023
- May 4th, 2023 12:00 pm
Scroll